- Package
- 1 g
- Purity
- 99%
- Price
- Request review
- Availability
- Shipping review required
- Delivery
- Shipping review required
CAS Number: 1187594-09-7
Submit an RFQ to review pricing, availability, lead time, pack size, purity, COA, and supplier SDS for this catalog entry.
Available options
Shipping review is required before pricing or stock can be confirmed publicly. Shipping, duties, and documentation fees are confirmed before order acceptance.
CAS Number
1187594-09-7
PubChem CID
44205240
Molecular Formula
C16H17N7O2S
Molecular Weight
371.4 g/mol
Exact Mass
371.116444
InChIKey
XUZMWHLSFXCVMG-UHFFFAOYSA-N
IUPAC Name
2-[1-ethylsulfonyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]azetidin-3-yl]acetonitrile
SMILES String
CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1
No physical property values available.
Properties are provided as catalog reference data and may be confirmed through supplier documentation when required.
Structural features
Baricitinib (CAS 1187594-09-7) is listed in the Pharmaceutical Intermediates portfolio, with molecular formula C16H17N7O2S and molecular weight 371. 40 g/mol.
Sourcing context
Catalog reference for RFQ preparation, supplier confirmation, and research chemical sourcing review.
Research use context
Intended for research-stage medicinal chemistry and intermediate synthesis workflows; structure-derived tags include nitrogen-containing heterocycle.
Documentation needs
COA/SDS status, availability, lead time, pack size, and shipment documentation can be confirmed during quotation.
ChEMBL reports experimental activity evidence for: Tyrosine-protein kinase JAK1 (Homo sapiens) — 29 assays; Tyrosine-protein kinase JAK2 (Homo sapiens) — 33 assays; JAK3/JAK1 (Homo sapiens) — 5 assays; AP2-associated protein kinase 1 (Homo sapiens) — 9 assays; Non-receptor tyrosine-protein kinase TYK2 (Homo sapiens) — 15 assays. These records describe research assays and do not establish therapeutic efficacy or clinical use.
Tyrosine-protein kinase JAK1
Homo sapiens · SINGLE PROTEIN · 29 qualifying assays · 27 documents · best pChEMBL 9.15
Experimental evidence source: ChEMBL
Tyrosine-protein kinase JAK2
Homo sapiens · SINGLE PROTEIN · 33 qualifying assays · 27 documents · best pChEMBL 9.1
Experimental evidence source: ChEMBL
JAK3/JAK1
Homo sapiens · PROTEIN COMPLEX · 5 qualifying assays · 4 documents · best pChEMBL 8.3
Experimental evidence source: ChEMBL
AP2-associated protein kinase 1
Homo sapiens · SINGLE PROTEIN · 9 qualifying assays · 7 documents · best pChEMBL 8.09
Experimental evidence source: ChEMBL
Non-receptor tyrosine-protein kinase TYK2
Homo sapiens · SINGLE PROTEIN · 15 qualifying assays · 14 documents · best pChEMBL 8.06
Experimental evidence source: ChEMBL
Safety and handling reference content is available through documentation requests.
For supplier-issued SDS, request documentation before handling, storage, shipment, or procurement decisions.
Preliminary Safety Reference
For supplier-issued SDS or COA, submit a documentation request.
Safety Reference / SDS RequestCatalog navigation
Other public CAS pages in this catalog. These links support navigation across additional intermediates and do not imply equivalence, availability, or shared use.
Baricitinib is identified by CAS 1187594-09-7, with molecular formula C16H17N7O2S, molecular weight 371.4, InChIKey XUZMWHLSFXCVMG-UHFFFAOYSA-N.
ChEMBL contains qualifying experimental assay evidence associated with Tyrosine-protein kinase JAK1, Tyrosine-protein kinase JAK2, JAK3/JAK1, AP2-associated protein kinase 1, Non-receptor tyrosine-protein kinase TYK2. These records do not establish therapeutic efficacy or clinical use.
Yes. Submit an RFQ and specify COA requirements. Lot-specific COA depends on supplier confirmation.
Yes. Supplier SDS can be requested through the RFQ workflow before handling, storage, shipment, or procurement decisions.
Availability, pack size, lead time, and pricing are confirmed through RFQ.
Submit the CAS number, quantity, purity requirement, and destination country for sourcing review.